Morgan Stanley’s Applied UV, Inc. Common Stock AUVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-384
Closed -$8.9K 7737
2023
Q2
$8.9K Buy
384
+380
+9,500% +$24K ﹤0.01% 6850
2023
Q1
$473 Sell
4
-26
-87% -$3.45K ﹤0.01% 7444
2022
Q4
$3.4K Buy
30
+27
+900% +$3.51K ﹤0.01% 7246
2022
Q3
$1K Sell
3
-34
-92% -$7.65K ﹤0.01% 7635
2022
Q2
$11K Buy
+37
New +$7.12K ﹤0.01% 7196
2022
Q1
Hold
0
8217
2021
Q4
Sell
-29
Closed -$18K 8194
2021
Q3
$26K Sell
29
-12
-29% -$11.5K ﹤0.01% 6997
2021
Q2
$51K Buy
+41
New +$47.4K ﹤0.01% 6667

Other funds holding AUVI

Morgan Stanley's AUVI Position: Q3 2023 in Review

Morgan Stanley sold out of Applied UV, Inc. Common Stock (AUVI) in Q3 2023, closing a stake of 384 shares — an estimated $8.9K sold.

Morgan Stanley first reported a position in AUVI in Q2 2021 and held it in 7 quarters. The position peaked at $51K in Q2 2021. 10 funds tracked by Wall St. Rank hold AUVI as of Q3 2023.

  • Morgan Stanley reported no remaining Applied UV, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Morgan Stanley sold 384 Applied UV, Inc. Common Stock shares in Q3 2023, an estimated $8.9K.
  • Morgan Stanley first reported a position in Applied UV, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • Morgan Stanley's Applied UV, Inc. Common Stock position peaked at $51K in Q2 2021.
  • 10 funds tracked by Wall St. Rank held Applied UV, Inc. Common Stock as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.